Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

about

Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.Interventions for Old World cutaneous leishmaniasis.

P2860

Q41677439-C32934D7-18CC-45E2-9567-A90E3A5E0465 Q46250558-93D8D19C-7D0C-4685-B4CA-01F314D65397

P2860

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

Item

http://www.wikidata.org/entity/Q53123885

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@en

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@nl

type

Item

label

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@en

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@nl

prefLabel

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@en

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@nl

P1476

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

@en

P2093

Mohsen Khoddami

http://www.w3.org/2001/XMLSchema#string

Omid Rajabi

http://www.w3.org/2001/XMLSchema#string

Pouran Layegh

http://www.w3.org/2001/XMLSchema#string

Sara Hashemzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Delivery systems to increase the selectivity of antibiotics in phagocytic cells.

Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice.

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.

Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis.

Efficacy of azithromycin in the treatment of cutaneous leishmaniasis.

Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro.

Azithromycin in the treatment of mucosal leishmaniasis.

Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.

P304

358-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DTH.12357

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27073044

http://www.w3.org/2001/XMLSchema#string

P921

azithromycin

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

about

P2860

P2860

Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921